Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce92a4d2fdab0cc5440f710c3787f38 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02 |
filingDate |
2007-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2e01b3c4c1dc9cf3dca6bb62f957f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184d600148aa9347cb69341c069a4c3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ad6e30ab388956f7ab8262f331f161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd07d945320511b9f8bd37d4428fc79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e31837fa3a144c3a8f872b92561f8e33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f290106aea7a084e469c762687f1718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0550de8b8d0a77ba41e26de53025e68 |
publicationDate |
2011-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DK-2001876-T3 |
titleOfInvention |
8-Azabicyclo [3.2.1] octane compounds as mu-opioid receptor antagonists |
priorityDate |
2006-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |